Advertisement
Screener

Amphastar Pharmaceuticals, Inc. (AMPH) Dividend Safety

Amphastar Pharmaceuticals, Inc. (AMPH) Dividend Safety

  • Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..

Dividend safety

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Dividend payout ratio · 12 months(m)Cash dividends paid / net income. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Dividend payments · 12 months(m)
Net income · 12 months78.55M USDNet Income (Loss) Attributable to Parent

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingDividend payments · 12 months (USD)Net income · 12 months (USD)Dividend payout
2026-06-30(m)$78.55M(m)
2026-03-31(m)$79.23M(m)
2025-12-31(m)$98.09M(m)
2025-09-30(m)$111.63M(m)
2025-06-30(m)$134.71M(m)
2025-03-31(m)$141.63M(m)
2024-12-31(m)$159.52M(m)
2024-09-30(m)$157.72M(m)
2024-06-30(m)$166.51M(m)
2024-03-31(m)$154.69M(m)
2023-12-31(m)$137.54M(m)
2023-09-30(m)$135.29M(m)
2023-06-30(m)$101.94M(m)
2023-03-31(m)$93.17M(m)
2022-12-31(m)$91.39M(m)
2022-09-30(m)$77.23M(m)
2022-06-30(m)$90.91M(m)
2022-03-31(m)$81.33M(m)
2021-12-31(m)$62.12M(m)
2021-09-30(m)$36.08M(m)
2021-06-30(m)$10.45M(m)
2021-03-31(m)$2.50M(m)
2020-12-31(m)$1.40M(m)
2020-09-30(m)$6.65M(m)
2020-06-30(m)$4.04M(m)
2020-03-31(m)$52.02M(m)
2019-12-31(m)$48.94M(m)
2019-09-30(m)$51.83M(m)
2019-06-30(m)$52.91M(m)
2019-03-31(m)$2.27M(m)
2018-12-31(m)$-5.74M(m)
2018-09-30(m)$-5.96M(m)
2018-06-30(m)$-8.39M(m)
2018-03-31(m)$-3.63M(m)
2017-12-31(m)$4.51M(m)
2017-09-30(m)$298.00K(m)
2017-06-30(m)$4.01M(m)
2017-03-31(m)$8.94M(m)
2016-12-31(m)$10.53M(m)
2016-09-30(m)$20.81M(m)
2016-06-30(m)$13.91M(m)
2016-03-31(m)$367.00K(m)
2015-12-31(m)$-2.79M(m)
2015-09-30(m)$-12.84M(m)
2015-06-30(m)$-15.21M(m)
2015-03-31(m)$-9.74M(m)
2014-12-31(m)$-10.70M(m)
2014-09-30(m)(m)(m)
2014-06-30(m)(m)(m)
2014-03-31(m)$7.86M(m)
2013-12-31(m)$11.86M(m)
2013-09-30(m)(m)(m)
2013-06-30(m)(m)(m)
2013-03-31(m)(m)(m)
2012-12-31(m)$18.09M(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
MANNKIND CORP (MNKD)United States$1.058B-30.41
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Jaguar Health, Inc. (JAGX)United States$1.184B
Savara Inc (SVRA)United States$1.044B-9.10
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87